SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001193125-13-167607
Filing Date
2013-04-23
Accepted
2013-04-23 17:02:14
Documents
2
Group Members
ORBIMED CAPITAL LLCSAMUEL D. ISALY

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D AMENDMENT NO. 4 d524896dsc13da.htm SC 13D/A 19841
2 EXHIBIT A d524896dex99a.htm EX-99.A 5876
  Complete submission text file 0001193125-13-167607.txt   27340
Mailing Address 601 LEXINGTON AVENUE 54TH FLOOR NEW YORK NY 10022
Business Address 601 LEXINGTON AVENUE 54TH FLOOR NEW YORK NY 10022 (212) 739-6400
ORBIMED ADVISORS LLC (Filed by) CIK: 0001055951 (see all company filings)

IRS No.: 133976876 | State of Incorp.: DE
Type: SC 13D/A

Mailing Address NO.3 A1, ROAD 10 SHENYANG ECONOMY & TECHNOLOGY DEVELOPMENT ZONE SHENYANG F4 110027
Business Address NO.3 A1, ROAD 10 SHENYANG ECONOMY & TECHNOLOGY DEVELOPMENT ZONE SHENYANG F4 110027 86-24-2581-1820
3SBio Inc. (Subject) CIK: 0001383790 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-82724 | Film No.: 13777085
SIC: 2834 Pharmaceutical Preparations